Interestingly, we discovered that ALB not only inhibits inflammation to improve liver fibrosis by targeting the CXCL12/CXCR4 axis, but also synergizes with MET to inhibit the progression of liver fibrosis. This evidence concerns the gene CXCR4 and Hepatic fibrosis.